Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2005 1
2006 1
2015 2
2016 1
2017 1
2018 1
2019 1
2020 5
2022 5
2023 9
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

26 results

Results by year

Filters applied: . Clear all
Page 1
Estrogen Receptor Beta (ERβ): A Ligand Activated Tumor Suppressor.
Mal R, Magner A, David J, Datta J, Vallabhaneni M, Kassem M, Manouchehri J, Willingham N, Stover D, Vandeusen J, Sardesai S, Williams N, Wesolowski R, Lustberg M, Ganju RK, Ramaswamy B, Cherian MA. Mal R, et al. Among authors: cherian ma. Front Oncol. 2020 Oct 23;10:587386. doi: 10.3389/fonc.2020.587386. eCollection 2020. Front Oncol. 2020. PMID: 33194742 Free PMC article. Review.
Operational Metrics for the ELAINE 2 Study Combining a Traditional Approach With a Just-in-TIME Model.
Blau S, Peguero JA, Moore HCF, Anderson IC, Barve MA, Cherian MA, Elkhanany A, O'Sullivan CC, Moreno-Aspitia A, Plourde P, Gleich LL, Riesen K, Ezzati R, Degele M, Shulman M, Stempf SD, Sachse L, Iyer AA, Damodaran S, Cooney MM. Blau S, et al. JCO Clin Cancer Inform. 2023 Jun;7:e2200164. doi: 10.1200/CCI.22.00164. JCO Clin Cancer Inform. 2023. PMID: 37352479 Free article.
The Immunomodulatory Effects of Dexamethasone on Neoadjuvant Chemotherapy for Triple-Negative Breast Cancer.
Johnson KCC, Goldstein D, Tharakan J, Quiroga D, Kassem M, Grimm M, Miah A, Vargo C, Berger M, Sudheendra P, Pariser A, Gatti-Mays ME, Williams N, Stover D, Sardesai S, Wesolowski R, Ramaswamy B, Tozbikian G, Schnell PM, Cherian MA. Johnson KCC, et al. Among authors: cherian ma. Oncol Ther. 2023 Sep;11(3):361-374. doi: 10.1007/s40487-023-00235-6. Epub 2023 Jun 24. Oncol Ther. 2023. PMID: 37354381 Free PMC article.
Depression, Inflammation, and Intestinal Permeability: Associations with Subjective and Objective Cognitive Functioning throughout Breast Cancer Survivorship.
Madison AA, Andridge R, Kantaras AH, Renna ME, Bennett JM, Alfano CM, Povoski SP, Agnese DM, Lustberg M, Wesolowski R, Carson WE 3rd, Williams NO, Reinbolt RE, Sardesai SD, Noonan AM, Stover DG, Cherian MA, Malarkey WB, Kiecolt-Glaser JK. Madison AA, et al. Among authors: cherian ma. Cancers (Basel). 2023 Sep 4;15(17):4414. doi: 10.3390/cancers15174414. Cancers (Basel). 2023. PMID: 37686689 Free PMC article.
TTF-1 Positive Primary Small Cell Carcinoma of the Breast: A Case Report and Review of the Literature.
Boutrid H, Kassem M, Tozbikian G, Morgan E, White J, Shah M, Vandeusen J, Sardesai S, Williams N, Stover DG, Lustberg M, Wesolowski R, Pudavalli V, Williams TM, Konda B, Fortier S, Carbone D, Ramaswamy B, Cherian MA. Boutrid H, et al. Among authors: cherian ma. Front Endocrinol (Lausanne). 2020 Apr 29;11:228. doi: 10.3389/fendo.2020.00228. eCollection 2020. Front Endocrinol (Lausanne). 2020. PMID: 32411090 Free PMC article. Review.
A 10-miRNA risk score-based prediction model for pathological complete response to neoadjuvant chemotherapy in hormone receptor-positive breast cancer.
Gong C, Cheng Z, Yang Y, Shen J, Zhu Y, Ling L, Lin W, Yu Z, Li Z, Tan W, Zheng C, Zheng W, Zhong J, Zhang X, Zeng Y, Liu Q, Huang RS, Komorowski AL, Yang ES, Bertucci F, Ricci F, Orlandi A, Franceschini G, Takabe K, Klimberg S, Ishii N, Toss A, Tan MP, Cherian MA, Song E. Gong C, et al. Among authors: cherian ma. Sci China Life Sci. 2022 Nov;65(11):2205-2217. doi: 10.1007/s11427-022-2104-3. Epub 2022 May 13. Sci China Life Sci. 2022. PMID: 35579777
Activity of Estrogen Receptor β Agonists in Therapy-Resistant Estrogen Receptor-Positive Breast Cancer.
Datta J, Willingham N, Manouchehri JM, Schnell P, Sheth M, David JJ, Kassem M, Wilson TA, Radomska HS, Coss CC, Bennett CE, Ganju RK, Sardesai SD, Lustberg M, Ramaswamy B, Stover DG, Cherian MA. Datta J, et al. Among authors: cherian ma. Front Oncol. 2022 Apr 25;12:857590. doi: 10.3389/fonc.2022.857590. eCollection 2022. Front Oncol. 2022. PMID: 35574319 Free PMC article.
Inflamed but not impulsive: Acute inflammatory cytokine response does not impact prepotent response inhibition.
Madison AA, Andridge R, Renna ME, Sheridan JF, Lustberg M, Ramaswamy B, Wesolowski R, Williams NO, Sardesai SD, Noonan AM, Reinbolt RE, Cherian MA, Malarkey WB, Kiecolt-Glaser JK. Madison AA, et al. Among authors: cherian ma. J Affect Disord. 2023 Dec 1;342:1-9. doi: 10.1016/j.jad.2023.09.008. Epub 2023 Sep 7. J Affect Disord. 2023. PMID: 37683942 Clinical Trial.
26 results